Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Organochlorine pesticide residues in human breast tissue and their relationships with clinical and pathological characteristics of breast cancer.

Ellsworth RE, Kostyniak PJ, Chi LH, Shriver CD, Costantino NS, Ellsworth DL.

Environ Toxicol. 2018 Jun 19. doi: 10.1002/tox.22573. [Epub ahead of print]

PMID:
29923341
2.

Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic?

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE.

Breast Cancer (Auckl). 2017 Feb 10;11:1178223417691246. doi: 10.1177/1178223417691246. eCollection 2017.

3.

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.

Ellsworth DL, Blackburn HL, Shriver CD, Rabizadeh S, Soon-Shiong P, Ellsworth RE.

Clin Transl Med. 2017 Dec;6(1):15. doi: 10.1186/s40169-017-0145-6. Epub 2017 Apr 12. Review.

4.

Lifestyle modification interventions differing in intensity and dietary stringency improve insulin resistance through changes in lipoprotein profiles.

Ellsworth DL, Costantino NS, Blackburn HL, Engler RJ, Kashani M, Vernalis MN.

Obes Sci Pract. 2016 Sep;2(3):282-292. Epub 2016 Jul 25.

5.

Molecular heterogeneity in breast cancer: State of the science and implications for patient care.

Ellsworth RE, Blackburn HL, Shriver CD, Soon-Shiong P, Ellsworth DL.

Semin Cell Dev Biol. 2017 Apr;64:65-72. doi: 10.1016/j.semcdb.2016.08.025. Epub 2016 Aug 26. Review.

6.

Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients.

Toro AL, Costantino NS, Shriver CD, Ellsworth DL, Ellsworth RE.

BMC Obes. 2016 Apr 29;3:22. doi: 10.1186/s40608-016-0103-7. eCollection 2016.

7.

Gene expression profiling during intensive cardiovascular lifestyle modification: Relationships with vascular function and weight loss.

Blackburn HL, McErlean S, Jellema GL, van Laar R, Vernalis MN, Ellsworth DL.

Genom Data. 2015 Mar 12;4:50-3. doi: 10.1016/j.gdata.2015.03.001. eCollection 2015 Jun.

8.

Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Ellsworth RE, Toro AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula KA, Costantino NS, Hooke JA, Shriver CD, Ellsworth DL.

Cancer Growth Metastasis. 2015 Jul 20;8:15-24. doi: 10.4137/CGM.S29490. eCollection 2015.

9.

Management of Incidental Findings in the Era of Next-generation Sequencing.

Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE.

Curr Genomics. 2015 Jun;16(3):159-74. doi: 10.2174/1389202916666150317232930.

10.

Importance of substantial weight loss for altering gene expression during cardiovascular lifestyle modification.

Ellsworth DL, Mamula KA, Blackburn HL, McDyer FA, Jellema GL, van Laar R, Costantino NS, Engler RJ, Vernalis MN.

Obesity (Silver Spring). 2015 Jun;23(6):1312-9. doi: 10.1002/oby.21079. Epub 2015 May 9.

11.

Abundance and distribution of polychlorinated biphenyls (PCBs) in breast tissue.

Ellsworth RE, Mamula KA, Costantino NS, Deyarmin B, Kostyniak PJ, Chi LH, Shriver CD, Ellsworth DL.

Environ Res. 2015 Apr;138:291-7. doi: 10.1016/j.envres.2015.02.025. Epub 2015 Mar 5.

PMID:
25749124
12.

Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.

Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE.

Cancer Causes Control. 2015 Mar;26(3):319-32. doi: 10.1007/s10552-014-0519-7. Epub 2015 Jan 3. Review.

PMID:
25554091
13.

Molecular response of the axillary lymph node microenvironment to metastatic colonization.

Valente AL, Kane JL, Ellsworth DL, Shriver CD, Ellsworth RE.

Clin Exp Metastasis. 2014 Jun;31(5):565-72. doi: 10.1007/s10585-014-9650-9. Epub 2014 Apr 1.

PMID:
24687565
14.

Intensive cardiovascular risk reduction induces sustainable changes in expression of genes and pathways important to vascular function.

Ellsworth DL, Croft DT Jr, Weyandt J, Sturtz LA, Blackburn HL, Burke A, Haberkorn MJ, McDyer FA, Jellema GL, van Laar R, Mamula KA, Chen Y, Vernalis MN.

Circ Cardiovasc Genet. 2014 Apr;7(2):151-60. doi: 10.1161/CIRCGENETICS.113.000121. Epub 2014 Feb 21.

15.

Recreational Music-Making alters gene expression pathways in patients with coronary heart disease.

Bittman B, Croft DT Jr, Brinker J, van Laar R, Vernalis MN, Ellsworth DL.

Med Sci Monit. 2013 Feb 25;19:139-47. doi: 10.12659/MSM.883807.

16.

Impact of lifestyle factors on prognosis among breast cancer survivors in the USA.

Ellsworth RE, Valente AL, Shriver CD, Bittman B, Ellsworth DL.

Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):451-64. doi: 10.1586/erp.12.37. Review.

PMID:
22971032
17.

Cardiometabolic risk reduction in an intensive cardiovascular health program.

Voeghtly LM, Neatrour DM, Decewicz DJ, Burke A, Haberkorn MJ, Lechak F, Patney HL, Vernalis MN, Ellsworth DL.

Nutr Metab Cardiovasc Dis. 2013 Jul;23(7):662-9. doi: 10.1016/j.numecd.2012.01.012. Epub 2012 May 26.

PMID:
22633795
18.

Laser microdissection for gene expression profiling.

Field LA, Deyarmin B, Shriver CD, Ellsworth DL, Ellsworth RE.

Methods Mol Biol. 2011;755:17-45. doi: 10.1007/978-1-61779-163-5_2.

PMID:
21761291
19.

Breast cancer in the personal genomics era.

Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL.

Curr Genomics. 2010 May;11(3):146-61. doi: 10.2174/138920210791110951.

20.

Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.

Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2010 Jun;17(6):1688-94. doi: 10.1245/s10434-010-0910-x. Epub 2010 Jan 27.

PMID:
20107913
21.

Genomic instability in the breast microenvironment? A critical evaluation of the evidence.

Holliday C, Rummel S, Hooke JA, Shriver CD, Ellsworth DL, Ellsworth RE.

Expert Rev Mol Diagn. 2009 Oct;9(7):667-78. doi: 10.1586/erm.09.55. Review.

PMID:
19817552
22.

Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy.

Decewicz DJ, Neatrour DM, Burke A, Haberkorn MJ, Patney HL, Vernalis MN, Ellsworth DL.

Lipids Health Dis. 2009 Jun 29;8:26. doi: 10.1186/1476-511X-8-26.

23.

Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Ellsworth RE, Hooke JA, Love B, Ellsworth DL, Shriver CD.

Pathol Oncol Res. 2009 Dec;15(4):541-7. doi: 10.1007/s12253-009-9151-3. Epub 2009 Feb 5.

PMID:
19194786
24.

Genomic heterogeneity of breast tumor pathogenesis.

Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL.

Clin Med Oncol. 2009 Jul 29;3:77-85.

25.

Environmental chemicals and breast cancer risk--a structural chemistry perspective.

Weyandt J, Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL.

Curr Med Chem. 2008;15(26):2680-701. Review.

PMID:
18991630
26.

Amplification of HER2 is a marker for global genomic instability.

Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Love B, Hooke JA, Shriver CD.

BMC Cancer. 2008 Oct 14;8:297. doi: 10.1186/1471-2407-8-297.

27.

Chromosomal alterations associated with the transition from in situ to invasive breast cancer.

Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD.

Ann Surg Oncol. 2008 Sep;15(9):2519-25. doi: 10.1245/s10434-008-0051-7. Epub 2008 Jul 12.

PMID:
18622645
28.

Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays.

Croft DT Jr, Jordan RM, Patney HL, Shriver CD, Vernalis MN, Orchard TJ, Ellsworth DL.

J Mol Diagn. 2008 May;10(3):249-57. doi: 10.2353/jmoldx.2008.070155. Epub 2008 Apr 10.

29.

Genomic alterations associated with early stages of breast tumor metastasis.

Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Hooke JA, Love B, Shriver CD.

Ann Surg Oncol. 2008 Jul;15(7):1989-95. doi: 10.1245/s10434-008-9902-5. Epub 2008 Apr 10.

PMID:
18401664
30.

The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.

Becker TE, Ellsworth RE, Deyarmin B, Patney HL, Jordan RM, Hooke JA, Shriver CD, Ellsworth DL.

Ann Surg Oncol. 2008 Apr;15(4):1056-63. doi: 10.1245/s10434-008-9815-3. Epub 2008 Feb 2.

PMID:
18246400
31.

Improvement in psychosocial functioning during an intensive cardiovascular lifestyle modification program.

Vizza J, Neatrour DM, Felton PM, Ellsworth DL.

J Cardiopulm Rehabil Prev. 2007 Nov-Dec;27(6):376-83; quiz 384-5. doi: 10.1097/01.HCR.0000300264.07764.84.

PMID:
18197071
32.

Genomic instability and the development of metastatic lymph node tumors.

Callaghan KA, Becker TE, Ellsworth DL, Hooke JA, Ellsworth RE, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3125-32. Epub 2007 Jul 25.

PMID:
17653592
33.

Correlation of levels and patterns of genomic instability with histological grading of DCIS.

Ellsworth RE, Ellsworth DL, Love B, Patney HL, Hoffman LR, Kane J, Hooke JA, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3070-7. Epub 2007 Jun 5.

PMID:
17549568
34.

Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors.

Ellsworth RE, Hooke JA, Love B, Kane JL, Patney HL, Ellsworth DL, Shriver CD.

Breast Cancer Res Treat. 2008 Jan;107(2):259-65. Epub 2007 Mar 10.

PMID:
17351743
35.

Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples.

Field LA, Jordan RM, Hadix JA, Dunn MA, Shriver CD, Ellsworth RE, Ellsworth DL.

Clin Biochem. 2007 Apr;40(7):499-502. Epub 2007 Jan 17.

PMID:
17303101
36.

Proteomic profiling of human urine using multi-dimensional protein identification technology.

Ru QC, Katenhusen RA, Zhu LA, Silberman J, Yang S, Orchard TJ, Brzeski H, Liebman M, Ellsworth DL.

J Chromatogr A. 2006 Apr 14;1111(2):166-74. Epub 2005 Jul 25.

PMID:
16569576
37.

Timing of critical genetic changes in human breast disease.

Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2005 Dec;12(12):1054-60. Epub 2005 Oct 10.

PMID:
16228814
38.

Interactive effects between polymorphisms in the beta-adrenergic receptors and longitudinal changes in obesity.

Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS.

Obes Res. 2005 Mar;13(3):519-26.

39.

Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.

Ellsworth RE, Ellsworth DL, Neatrour DM, Deyarmin B, Lubert SM, Sarachine MJ, Brown P, Hooke JA, Shriver CD.

Mol Cancer Res. 2005 Feb;3(2):71-7.

40.

Genomic instability in histologically normal breast tissues: implications for carcinogenesis.

Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD.

Lancet Oncol. 2004 Dec;5(12):753-8. Review.

PMID:
15581548
41.

Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.

Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Shriver CD.

Breast Cancer Res Treat. 2004 Nov;88(2):131-9.

PMID:
15564796
42.

Intensive lifestyle modification: impact on cardiovascular disease risk factors in subjects with and without clinical cardiovascular disease.

Ellsworth DL, O'Dowd SC, Salami B, Hochberg A, Vernalis MN, Marshall D, Morris JA, Somiari RI.

Prev Cardiol. 2004 Fall;7(4):168-75.

43.

Outer breast quadrants demonstrate increased levels of genomic instability.

Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Hooke JA, Shriver CD.

Ann Surg Oncol. 2004 Sep;11(9):861-8. Epub 2004 Aug 16.

PMID:
15313734
44.

Functional relationship and gene ontology classification of breast cancer biomarkers.

Arciero C, Somiari SB, Shriver CD, Brzeski H, Jordan R, Hu H, Ellsworth DL, Somiari RI.

Int J Biol Markers. 2003 Oct-Dec;18(4):241-72. Review.

PMID:
14756541
45.

High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer.

Ellsworth RE, Ellsworth DL, Lubert SM, Hooke J, Somiari RI, Shriver CD.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):915-9.

46.

Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.

Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, Mitchell BD, Norris JM, Rewers M, Saad MF, Stamm E, Wagenknecht LE, Rich SS.

Ann Epidemiol. 2003 Apr;13(4):211-7.

PMID:
12684185
47.

Laser capture microdissection of paraffin-embedded tissues.

Ellsworth DL, Shriver CD, Ellsworth RE, Deyarmin B, Somiari RI.

Biotechniques. 2003 Jan;34(1):42-4, 46. No abstract available.

PMID:
12545536
48.

Slow molecular clocks in Old World monkeys, apes, and humans.

Yi S, Ellsworth DL, Li WH.

Mol Biol Evol. 2002 Dec;19(12):2191-8.

PMID:
12446810
49.

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations.

Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, Hanson J, Khoury M, Lau J, O'Brien TR, Rothman N, Stroup D, Taioli E, Thomas D, Vainio H, Wacholder S, Weinberg C.

Am J Epidemiol. 2002 Aug 15;156(4):300-10. Review.

PMID:
12181099
50.

Heritability of coronary artery calcium quantity measured by electron beam computed tomography in asymptomatic adults.

Peyser PA, Bielak LF, Chu JS, Turner ST, Ellsworth DL, Boerwinkle E, Sheedy PF 2nd.

Circulation. 2002 Jul 16;106(3):304-8.

Supplemental Content

Loading ...
Support Center